⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL980114 | 0.80 | — | — | |
| SCHEMBL1521573 | 0.78 | HSP90AA1 (0.43) | — | |
| SCHEMBL978915 | 0.75 | — | — | |
| SCHEMBL246396 | 0.74 | — | — | |
| SCHEMBL284256 | 0.74 | — | — | |
| SCHEMBL344601 | 0.74 | — | — | |
| SCHEMBL3112201 | 0.74 | — | — | |
| SCHEMBL12431 | 0.74 | — | — | |
| SCHEMBL291279 | 0.74 | — | — | |
| SCHEMBL7692978 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5004732-A | Treatment of acne | SOCIETE ANONYME DITE: L'OREAL (FR) | 1991-04-02 | — | — | US | claimed |
| JP-2292266-A | — | — | None | — | — | JP | disclosed |
| US-5019576-A | Anticoagulants | SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) (FR) | 1991-05-28 | — | — | US | disclosed |
| US-5004732-A | Treatment of acne | SOCIETE ANONYME DITE: L'OREAL (FR) | 1991-04-02 | — | — | US | disclosed |
| JP-H02292266-A | PIPERAZINE DERIVATIVE, ITS PRODUCTION AND THERAPEUTIC COMPOSITION CONTAINING THE SAME | SOC CONSEILS RECH APPL SCIENT SA (SCRAS) | 1990-12-03 | — | — | JP | disclosed |
| US-4638005-A | ELECTRON CARRIERS IN THE PHOTOENZYMATIC PRODUCTION OF HYDROGEN AND AMMONIA | THE COCA-COLA COMPANY | 1987-01-20 | — | — | US | disclosed |
| US-4183933-A | TREATMENT OF MENTAL ILLNESS, NEUROSIS, BEHAVIORAL DISTURBANCES, INFLAMMATION, ANOREXIA, AND CARDIAC AND VASCULAR DISORDERS | AB FERROSAN (SE) | 1980-01-15 | — | — | US | disclosed |